- Home
- KGEI vs BDTX Comparison
KGEI vs BDTX Comparison
Compare KGEI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGEI
- BDTX
- Stock Information
- Founded
- KGEI 2008
- BDTX 2014
- Country
- KGEI United States
- BDTX United States
- Employees
- KGEI N/A
- BDTX N/A
- Industry
- KGEI
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KGEI
- BDTX Health Care
- Exchange
- KGEI Nasdaq
- BDTX Nasdaq
- Market Cap
- KGEI 163.1M
- BDTX 181.4M
- IPO Year
- KGEI N/A
- BDTX 2020
- Fundamental
- Price
- KGEI $4.61
- BDTX $4.02
- Analyst Decision
- KGEI Strong Buy
- BDTX Strong Buy
- Analyst Count
- KGEI 1
- BDTX 5
- Target Price
- KGEI $11.00
- BDTX $10.40
- AVG Volume (30 Days)
- KGEI 77.1K
- BDTX 988.1K
- Earning Date
- KGEI 11-11-2025
- BDTX 11-05-2025
- Dividend Yield
- KGEI N/A
- BDTX N/A
- EPS Growth
- KGEI 35.27
- BDTX N/A
- EPS
- KGEI 0.54
- BDTX 0.25
- Revenue
- KGEI $57,936,000.00
- BDTX $70,000,000.00
- Revenue This Year
- KGEI $14.07
- BDTX N/A
- Revenue Next Year
- KGEI $26.69
- BDTX N/A
- P/E Ratio
- KGEI $8.41
- BDTX $15.70
- Revenue Growth
- KGEI 6.52
- BDTX N/A
- 52 Week Low
- KGEI $2.91
- BDTX $1.20
- 52 Week High
- KGEI $9.89
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- KGEI 32.74
- BDTX 57.23
- Support Level
- KGEI $4.29
- BDTX $3.67
- Resistance Level
- KGEI $4.80
- BDTX $4.45
- Average True Range (ATR)
- KGEI 0.19
- BDTX 0.26
- MACD
- KGEI -0.06
- BDTX -0.04
- Stochastic Oscillator
- KGEI 22.70
- BDTX 46.15
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.